Selenium and Other Supplements for Hair Loss
For hair loss management, selenium supplementation should be reserved for documented deficiency states only, as there is no evidence supporting routine selenium supplementation for typical alopecia patterns, while vitamin D and iron deficiencies should be actively screened and corrected based on specific serum thresholds.
Selenium: Limited Role
Selenium supplementation for hair loss lacks robust evidence in typical alopecia cases. The available data shows:
Deficiency-related hair loss: Selenium deficiency can cause alopecia in specific contexts (parenteral nutrition patients), with rapid clinical response when selenite is supplemented 1. However, this represents a rare, iatrogenic scenario rather than common hair loss presentations.
No routine supplementation indicated: The evidence does not support selenium supplementation for androgenetic alopecia (AGA), female pattern hair loss (FAGA), or telogen effluvium unless documented deficiency exists.
Combination products: One 2023 study showed that an oral supplement containing selenium (along with hydrolyzed collagen, amino acids, and iron) improved outcomes when added to standard hair loss treatments, with 50% achieving significant improvement versus 23% with treatment alone 2. However, this was a combination product making it impossible to isolate selenium's specific contribution.
Vitamin D: Strong Association with Alopecia Areata
Vitamin D deficiency is strongly associated with alopecia areata (AA) and should be screened and corrected:
Deficiency threshold: Multiple case-control studies demonstrate lower 25(OH)D levels in AA patients, with deficiency defined as <20 ng/mL (50 nmol/L) 3.
Severity correlation: Vitamin D levels inversely correlate with AA severity using the SALT score (P < 0.001, r = −0.41) 3. Lower levels associate with more extensive hair loss.
Screening recommendation: Check serum 25(OH)D levels in all AA patients. Supplementation is reasonable when deficiency is documented, though controlled trials specifically demonstrating hair regrowth with vitamin D supplementation in AA are lacking 3.
Important caveat: The vitamin D receptor (VDR) appears more critical than the ligand itself for hair follicle function, as mouse studies show alopecia develops with VDR knockout even when vitamin D is present 3.
Iron: Target Specific Ferritin Levels
For unexplained diffuse hair loss, particularly in at-risk populations:
Ferritin threshold: Target serum ferritin ≥70 μg/L when hair loss is unexplained 1. This is higher than the threshold for diagnosing iron deficiency anemia.
Limited evidence: While iron depletion may relate to diffuse hair loss, there is insufficient data correlating cessation of hair loss with iron therapy in patients without anemia 1.
Do not supplement blindly: Iron supplementation should not be given without documented deficiency or low ferritin levels.
Other Micronutrients
Zinc: Most frequently suspected micronutrient deficiency in hair loss, with rapid clinical responses reported from zinc therapy 1. However, the evidence provided does not specify dosing or monitoring parameters.
Biotin: Routine supplementation in parenteral nutrition has eliminated biotin deficiency-related alopecia. Marginal biotin status could still manifest as diffuse hair loss, but prevalence and supplementation efficacy remain unstudied 1.
Monitoring Approach
For patients with unexplained hair loss:
- Check serum 25(OH)D levels (especially in AA patients)
- Check serum ferritin (target ≥70 μg/L for unexplained diffuse hair loss)
- Consider zinc levels if clinical suspicion exists
- Supplement only documented deficiencies with appropriate monitoring
Critical Pitfall
Avoid empiric supplementation without documented deficiency. The combination supplement study 2 showing benefit included multiple active ingredients (collagen, amino acids, iron, selenium), making it impossible to determine which components drove efficacy. Selenium's role in typical hair loss patterns remains unproven outside of rare deficiency states.